Aceragen Inc (ACGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 12-2021 | 12-2020 | 12-2019 | 12-2018 | |
| Sales | 4,862 | 0 | 0 | 1,448 | 662 |
| Gross Profit | 4,862 | N/A | N/A | 1,448 | 662 |
| Operating Expenses | 32,680 | 27,673 | 36,687 | 47,515 | 61,618 |
| Operating Income | -27,818 | -27,673 | -36,687 | -46,067 | -60,956 |
| Interest Expense | -204 | -2 | 3 | 0 | 11 |
| Other Income | -2,064 | 125,762 | -75,972 | -10,448 | 1,086 |
| Pre-tax Income | -29,678 | 98,091 | -112,662 | -56,515 | -59,881 |
| Income Tax | -6,318 | 0 | N/A | N/A | N/A |
| Net Income Continuous | -23,360 | 98,091 | -112,662 | -56,515 | -59,881 |
| Net Income | $-23,360 | $98,091 | $-112,662 | $-56,515 | $-59,881 |
| EPS Basic Total Ops | -7.18 | 33.49 | -56.63 | -50.34 | -38.27 |
| EPS Basic Continuous Ops | -7.18 | 33.89 | -56.65 | -33.67 | -38.28 |
| EPS Diluted Total Ops | -7.18 | -9.78 | -56.63 | -50.34 | -38.27 |
| EPS Diluted Continuous Ops | -7.18 | 33.27 | -56.65 | -33.67 | -38.28 |
| EPS Diluted Before Non-Recurring Items | -7.18 | -9.86 | -18.37 | -26.70 | -38.78 |
| EBITDA(a) | $-27,803 | $-27,651 | $-36,626 | $-45,947 | $-60,524 |